EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of Carbonic Anhydrase 9 as a Novel CLEC2 Ligand in a Cellular Interactome Screen

Sebastian Hoffmann iD, Benedict-Tilman Berger iD, Liane Rosalie Lucas, Felix Schiele, John Edward Park iD

Cells · 2024

DOI: 10.3390/cells13242083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Sebastian Hoffmann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Immunology and Immune Modulation, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach, Germany. Hauptthemen laut MEDLINE: Lectins, C-Type, Protein Binding, Carbonic Anhydrase IX. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Membrane proteins, especially extracellular domains, are key therapeutic targets due to their role in cell communication and associations. Yet, their functions and interactions often remain unclear. This study presents a general method to discover interactions of membrane proteins with immune cells and subsequently to deorphanize their respective receptors. We developed a comprehensive recombinant protein library of extracellular domains of human transmembrane proteins and proteins found in the ER-Golgi-lysosomal systems. Using this library, we conducted a flow-cytometric screen that identified several cell surface binding events, including an interaction between carbonic anhydrase 9 (CAH9/CA9/CAIX) and CD14high cells. Further analysis revealed this interaction was indirect and mediated via platelets bound to the monocytes. CA9, best known for its diverse roles in cancer, is a promising therapeutic target. We utilized our library to develop an AlphaLISA high-throughput screening assay, identifying CLEC2 as one robust CA9 binding partner. A five-amino-acid sequence (EDLPT) in CA9, identical to a CLEC2 binding domain in Podoplanin (PDPN), was found to be essential for this interaction. Like PDPN, CA9-induced CLEC2 signaling is mediated via Syk. A Hodgkin’s lymphoma cell line (HDLM-2) endogenously expressing CA9 can activate Syk-dependent CLEC2 signaling, providing enticing evidence for a novel function of CA9 in hematological cancers. In conclusion, we identified numerous interactions with monocytes and platelets and validated one, CA9, as an endogenous CLEC2 ligand. We provide a new list of other putative CA9 interaction partners and uncovered CA9-induced CLEC2 activation, providing new insights for CA9-based therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lectins, C-TypeProtein BindingCarbonic Anhydrase IXHumansLigandsMonocytesSyk KinaseBlood PlateletsSignal TransductionAntigens, NeoplasmMembrane Glycoproteins

Stichwörter der Autor:innen

AlphaLISA screenC-type lectin-like receptor 2 (CLEC2)CAH9CAIX)Hodgkin’s lymphomaSYKblood cancercarbonic anhydrase 9 (CA9cell-cell interactionsdeorphanizationmonocyte/platelet membrane protein interactomeplatelet-tumor cell aggregationpodoplanin (PDPN)protein-protein interactionsreceptor screen

Substanzen

Lectins, C-TypeLigandsCarbonic Anhydrase IXCLEC2B protein, humanCA9 protein, humanSyk KinaseAntigens, NeoplasmSYK protein, humanMembrane Glycoproteins

Autor:innen und Institutionen

  • Division of Cancer Immunology and Immune Modulation, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach, Germany.
  • Division of High-Throughput Biology, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach, Germany.
  • Division of Biotherapeutics Discovery, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach, Germany.

ORCID-Profile: Sebastian Hoffmann, Benedict-Tilman Berger, John Edward Park

Förderung

  • Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
  • Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany

Zitieren

APA

Hoffmann, S., Berger, B. T., Lucas, L. R., Schiele, F., & Park, J. E. (2024). Discovery of Carbonic Anhydrase 9 as a Novel CLEC2 Ligand in a Cellular Interactome Screen. Cells. https://doi.org/10.3390/cells13242083

Vancouver

Hoffmann S, Berger BT, Lucas LR, Schiele F, Park JE. Discovery of Carbonic Anhydrase 9 as a Novel CLEC2 Ligand in a Cellular Interactome Screen. Cells. 2024. doi:10.3390/cells13242083

BibTeX
@article{Hoffmann2024,
  author = {Hoffmann, Sebastian and Berger, Benedict-Tilman and Lucas, Liane Rosalie and Schiele, Felix and Park, John Edward},
  title = {Discovery of Carbonic Anhydrase 9 as a Novel CLEC2 Ligand in a Cellular Interactome Screen},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13242083}
}
Kostenlos starten →